Free Trial
NASDAQ:CAPS

Capstone Therapeutics (CAPS) Stock Price, News & Analysis

Capstone Therapeutics logo
$1.61 +0.18 (+12.59%)
As of 07/11/2025 03:59 PM Eastern

About Capstone Therapeutics Stock (NASDAQ:CAPS)

Key Stats

Today's Range
$1.43
$1.67
50-Day Range
$1.36
$2.45
52-Week Range
$1.30
$16.18
Volume
107,566 shs
Average Volume
83,531 shs
Market Capitalization
$257.60 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CAPS Stock News Headlines

Michael Parker
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
A capstone project
Capstone Holding Corp. (J7W.F)
See More Headlines

CAPS Stock Analysis - Frequently Asked Questions

Capstone Therapeutics' stock was trading at $2.40 at the start of the year. Since then, CAPS shares have decreased by 32.9% and is now trading at $1.61.

Capstone Therapeutics (CAPS) raised $5 million in an initial public offering on Thursday, March 6th 2025. The company issued 1,250,000 shares at $4.00 per share.

Capstone Therapeutics's lock-up period expires on Tuesday, September 2nd. Capstone Therapeutics had issued 1,250,000 shares in its IPO on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. After the expiration of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CAPS
CIK
887151
Web
N/A
Employees
38
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
1.14
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$44.88 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($19.40) per share
Price / Book
-0.08

Miscellaneous

Outstanding Shares
160,000
Free Float
90,000
Market Cap
$257.60 thousand
Optionable
N/A
Beta
-0.82
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:CAPS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners